Work in HR? Unlock Free Profile

Cytokinetics Reviews

7 Reviews
7 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
Cytokinetics President, CEO, and Director Robert I. Blum
Robert I. Blum
4 Ratings

    It felt like family here and I wish I were still there (I was part of the lay offs).

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Former Employee - Human Resources Coordinator  in  South San Francisco, CA
    Former Employee - Human Resources Coordinator in South San Francisco, CA

    I worked at Cytokinetics full-time for more than a year


    Excellent work environment, culture & people. It was a very familial, friendly place to work and the type of place where you enjoyed coming into work every day.


    I don't think I would have had the opportunity to grow here because it was such a small department that there probably wouldn't have been anywhere for me to go.

    Neutral Outlook
    Approves of CEO

Cytokinetics Interviews

Interview Experience

Interview Experience


Getting an Interview

Getting an Interview


Interview Difficulty


Interview Difficulty



  1. 1 person found this helpful  

    R&D Interview

    Anonymous Interview Candidate  in  South San Francisco, CA
    Anonymous Interview Candidate in South San Francisco, CA
    Application Details

    I applied online. The process took 4 weeks - interviewed at Cytokinetics in October 2007.

    Interview Details

    Responded to Craigslist ad, phone screen with staff member, then 1:1 interview with hiring manager and team members. Positive overall first impressions regarding knowledge and competency

    Negotiation Details
    Accepted Offer
    Positive Experience
    Easy Interview

Cytokinetics Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Edit Profile
Headquarters South San Francisco, CA
Size 50 to 149 Employees
Founded Unknown
Type Company - Public (CYTK)
Industry Biotech & Pharmaceuticals
Revenue $25 to $50 million (USD) per year

Cytokinetics studies the cytoskeleton to get to the heart of the problem. The biopharmaceutical firm's drug development technologies aim to treat disease by modulating muscle function through manipulation of the cytoskeleton (biological infrastructure of cells). Its pipeline includes lead candidate omecamtiv mecarbil, which is designed for the treatment of heart failure based on a cytoskeletal protein in the heart muscle. It is being developed in collaboration with Amgen. Its other lead candidate, CK-2017357, is in development as a treatment for amyotrophic lateral... More

Worked for Cytokinetics? Contribute to the Community!